The Kaplan–Meier analyses also indicated that patients with high HPCAL1 expression had shorter OS and higher recurrence rates than those with low expression (Figure 5C), which further highlights the crucial role of HPCAL1 in CCA progression. This evidence concerns the gene HPCAL1 and cholangiocarcinoma.